Hartmann A - Search Results

1

Ultraviolet-excited (308 nm) autofluorescence for bladder cancer detection.

Zaak D, Stepp H, Baumgartner R, Schneede P, Waidelich R, Frimberger D, Hartmann A, Künchel R, Hofstetter A, Hohla A. Zaak D, et al. Among authors: hartmann a. Urology. 2002 Dec;60(6):1029-33. doi: 10.1016/s0090-4295(02)01999-4. Urology. 2002. PMID: 12475664

2

Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma.

Hartmann A, Moser K, Kriegmair M, Hofstetter A, Hofstaedter F, Knuechel R. Hartmann A, et al. Am J Pathol. 1999 Mar;154(3):721-7. doi: 10.1016/S0002-9440(10)65318-7. Am J Pathol. 1999. PMID: 10079249 Free PMC article.

3

Clonality and genetic divergence in multifocal low-grade superficial urothelial carcinoma as determined by chromosome 9 and p53 deletion analysis.

Hartmann A, Rösner U, Schlake G, Dietmaier W, Zaak D, Hofstaedter F, Knuechel R. Hartmann A, et al. Lab Invest. 2000 May;80(5):709-18. doi: 10.1038/labinvest.3780074. Lab Invest. 2000. PMID: 10830781 Free article.

4

Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder.

Hartmann A, Schlake G, Zaak D, Hungerhuber E, Hofstetter A, Hofstaedter F, Knuechel R. Hartmann A, et al. Cancer Res. 2002 Feb 1;62(3):809-18. Cancer Res. 2002. PMID: 11830537

5

Molecular genetic evaluation of fluorescence diagnosis in bladder cancer.

Junker K, Kania K, Fiedler W, Hartmann A, Schubert J, Werner W. Junker K, et al. Among authors: hartmann a. Int J Oncol. 2002 Mar;20(3):647-53. Int J Oncol. 2002. PMID: 11836583

6

No evidence for involvement of beta-catenin and APC in urothelial carcinomas.

Stoehr R, Krieg RC, Knuechel R, Hofstaedter F, Pilarsky C, Zaak D, Schmitt R, Hartmann A. Stoehr R, et al. Among authors: hartmann a. Int J Oncol. 2002 May;20(5):905-11. Int J Oncol. 2002. PMID: 11956582

7

Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses.

Obermann EC, Junker K, Stoehr R, Dietmaier W, Zaak D, Schubert J, Hofstaedter F, Knuechel R, Hartmann A. Obermann EC, et al. Among authors: hartmann a. J Pathol. 2003 Jan;199(1):50-7. doi: 10.1002/path.1259. J Pathol. 2003. PMID: 12474226

8

[Precancerous conditions in the urothelium. Early detection and molecular understanding through endoscopic fluorescence diagnosis].

Knüchel R, Hartmann A, Stöhr R, Baumgartner R, Zaak D, Krieg RC. Knüchel R, et al. Among authors: hartmann a. Pathologe. 2003 Oct;24(6):473-9. doi: 10.1007/s00292-003-0651-8. Pathologe. 2003. PMID: 14605854 German.

9

Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer.

Stoehr R, Wissmann C, Suzuki H, Knuechel R, Krieg RC, Klopocki E, Dahl E, Wild P, Blaszyk H, Sauter G, Simon R, Schmitt R, Zaak D, Hofstaedter F, Rosenthal A, Baylin SB, Pilarsky C, Hartmann A. Stoehr R, et al. Among authors: hartmann a. Lab Invest. 2004 Apr;84(4):465-78. doi: 10.1038/labinvest.3700068. Lab Invest. 2004. PMID: 14968126 Free article.

10

Fluorescence in situ hybridization detects frequent chromosome 9 deletions and aneuploidy in histologically normal urothelium of bladder cancer patients.

Obermann EC, Meyer S, Hellge D, Zaak D, Filbeck T, Stoehr R, Hofstaedter F, Hartmann A, Knuechel R. Obermann EC, et al. Among authors: hartmann a. Oncol Rep. 2004 Apr;11(4):745-51. Oncol Rep. 2004. PMID: 15010867

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,452 results

Search Page

Filters